Healthcare provider profile · identity verified

Paul Schmidt, D.O.

Internal Medicine · LOGAN, UT · NPI 1598992570

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	742	181
Levothyroxine Sodium	Levothyroxine Sodium	588	132
Omeprazole	Omeprazole	575	129
Gabapentin	Gabapentin	403	79
Duloxetine Hcl	Duloxetine Hcl	367	73
Losartan Potassium	Losartan Potassium	345	92
Lisinopril	Lisinopril	340	91
Amlodipine Besylate	Amlodipine Besylate	323	94
Metformin Hcl	Metformin Hcl	279	70
Trazodone Hcl	Trazodone Hcl	254	42
Rosuvastatin Calcium	Rosuvastatin Calcium	235	69
Hydrochlorothiazide	Hydrochlorothiazide	227	70
Metformin Hcl Er	Metformin Hcl	195	53
Tramadol Hcl	Tramadol Hcl	188	27
Bupropion Xl	Bupropion Hcl	185	27
Pravastatin Sodium	Pravastatin Sodium	176	44
Metoprolol Succinate	Metoprolol Succinate	174	38
Eliquis	Apixaban	173	31
Potassium Chloride	Potassium Chloride	160	37
Simvastatin	Simvastatin	153	40
Pantoprazole Sodium	Pantoprazole Sodium	152	36
Zolpidem Tartrate	Zolpidem Tartrate	148	27
Fluticasone Propionate	Fluticasone Propionate	146	61
Jardiance	Empagliflozin	134	20
Alendronate Sodium	Alendronate Sodium	131	42
Citalopram Hbr	Citalopram Hydrobromide	124	24
Furosemide	Furosemide	124	37
Tamsulosin Hcl	Tamsulosin Hcl	123	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	31
Mirtazapine	Mirtazapine	120	25
Mounjaro	Tirzepatide	115	22
Sertraline Hcl	Sertraline Hcl	112	30
Baclofen	Baclofen	98	15
Buspirone Hcl	Buspirone Hcl	94	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	94	13
Escitalopram Oxalate	Escitalopram Oxalate	91	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	91	28
Famotidine	Famotidine	89	16
Fluoxetine Hcl	Fluoxetine Hcl	89	23
Carvedilol	Carvedilol	78	23
Pregabalin	Pregabalin	78	19
Spironolactone	Spironolactone	77	14
Celecoxib	Celecoxib	76	23
Topiramate	Topiramate	76	17
Xarelto	Rivaroxaban	75	15
Soliqua 100-33	Insulin Glargine/Lixisenatide	73	12
Meloxicam	Meloxicam	72	21
Chlorthalidone	Chlorthalidone	71	22
Metoprolol Tartrate	Metoprolol Tartrate	71	19
Allopurinol	Allopurinol	70	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	68	17
Alprazolam	Alprazolam	67	15
Ezetimibe	Ezetimibe	67	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	20
Estradiol	Estradiol	64	16
Montelukast Sodium	Montelukast Sodium	63	17
Clonazepam	Clonazepam	62	13
Promethazine Hcl	Promethazine Hcl	62	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	60	12
Albuterol Sulfate Hfa	Albuterol Sulfate	53	26
Lorazepam	Lorazepam	52	11
Pioglitazone Hcl	Pioglitazone Hcl	51	16
Ropinirole Hcl	Ropinirole Hcl	51	15
Hydroxyzine Hcl	Hydroxyzine Hcl	50	12
Ozempic	Semaglutide	50	14
Amitriptyline Hcl	Amitriptyline Hcl	48	11
Paroxetine Hcl	Paroxetine Hcl	45	suppressed
Propranolol Hcl Er	Propranolol Hcl	43	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	43	12
Tizanidine Hcl	Tizanidine Hcl	42	14
Levetiracetam	Levetiracetam	41	suppressed
Naproxen	Naproxen	41	suppressed
Donepezil Hcl	Donepezil Hcl	36	suppressed
Ondansetron Odt	Ondansetron	35	17
Zolpidem Tartrate Er	Zolpidem Tartrate	35	suppressed
Propranolol Hcl	Propranolol Hcl	34	suppressed
Ramipril	Ramipril	34	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	suppressed
Finasteride	Finasteride	32	11
Pen Needle	Pen Needle, Diabetic	32	11
Ibuprofen	Ibuprofen	31	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	31	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Rybelsus	Semaglutide	30	suppressed
Solifenacin Succinate	Solifenacin Succinate	30	suppressed
Divalproex Sodium Er	Divalproex Sodium	29	suppressed
Fenofibrate	Fenofibrate	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	14
Enalapril Maleate	Enalapril Maleate	27	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	27	23
Sucralfate	Sucralfate	27	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Buprenorphine	Buprenorphine	25	suppressed
Ciclopirox	Ciclopirox	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Glimepiride	Glimepiride	24	11
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Myrbetriq	Mirabegron	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	14
Risedronate Sodium	Risedronate Sodium	21	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	20	suppressed
Liothyronine Sodium	Liothyronine Sodium	20	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Diazepam	Diazepam	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Desmopressin Acetate	Desmopressin Acetate	18	suppressed
Linzess	Linaclotide	18	suppressed
Prednisone	Prednisone	18	11
Creon	Lipase/Protease/Amylase	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Folic Acid	Folic Acid	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	suppressed
Dexlansoprazole Dr	Dexlansoprazole	16	suppressed
Fluconazole	Fluconazole	16	13
Lovastatin	Lovastatin	16	suppressed
Novolog	Insulin Aspart	16	suppressed
Atenolol	Atenolol	15	suppressed
Clobazam	Clobazam	15	suppressed
Glyburide	Glyburide	15	suppressed
Insulin Lispro	Insulin Lispro	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	11
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Glipizide	Glipizide	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Torsemide	Torsemide	14	suppressed
Amoxicillin	Amoxicillin	13	12
Carisoprodol	Carisoprodol	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	11
Drospirenone-Ethinyl Estradiol	Ethinyl Estradiol/Drospirenone	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Baqsimi	Glucagon	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Humalog Kwikpen U-200	Insulin Lispro	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Primidone	Primidone	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error